Given our finding that CLDN6 is associated with ferroptosis in breast cancer patients, CLDN6 triggering ferroptosis in breast cancer cells was subsequently observed in terms of cell viability, ultrastructure, and biochemical processes. This evidence concerns the gene CLDN6 and breast carcinoma.